CD274 and triple-negative breast carcinoma: Importantly, one study showed the potential immunomodulatory effect of fucoidan on breast cancer cells through the de PDL-1 axis, and all the effects were observed in triple-negative breast cancer cells (MDA-MB-231 and 4T1 cells) or estrogen-sensitive cells (MCF-7).